© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to September
penicillin-binding protein + _-lactamase inh.
preclin. eff. at 50 mpk SC, 2,000 mpk tolerated
multitarget SBDD + opt. for porin permeability
The Entasis broad-spectrum antibiotic, ETX0462, is both an inhibitor of penicillin-binding proteins (PBPs, the target of beta-lactams) and a beta-lactamase inhibitor (BLI). Reviewer Mike Koehler thought this was a substantial disclosure. “A…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.